Legis Daily

PREVENT HPV Cancers Act of 2021

USA117th CongressHR-1550| House 
| Updated: 12/1/2021
Kathy Castor

Kathy Castor

Democratic Representative

Florida

Cosponsors (16)
Kim Schrier (Democratic)Stephanie N. Murphy (Democratic)Lisa Blunt Rochester (Democratic)Chrissy Houlahan (Democratic)Darren Soto (Democratic)Raul Ruiz (Democratic)Terri A. Sewell (Democratic)Madeleine Dean (Democratic)Paul Tonko (Democratic)Thomas R. Suozzi (Democratic)Brendan F. Boyle (Democratic)Mark DeSaulnier (Democratic)G. K. Butterfield (Democratic)Marilyn Strickland (Democratic)Mary Gay Scanlon (Democratic)Brian K. Fitzpatrick (Republican)

Health, Education, Labor, and Pensions Committee, Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Promoting Resources to Expand Vaccination, Education, and New Treatments for HPV Cancers Act of 2021 or the PREVENT HPV Cancers Act of 2021 This bill reauthorizes through FY2026 and expands Department of Health and Human Services activities to educate health care providers and the public about human papillomavirus (HPV), its association with certain cancers, and the importance of HPV vaccines. Specifically, the bill (1) requires relevant educational materials to include information about both cervical cancer and other HPV-associated cancers and about the importance of HPV vaccines, including for males; (2) expands the scope of a national education campaign about gynecologic cancers to address HPV-associated cancers more broadly and target specified, at-risk populations; and (3) authorizes demonstration projects to increase knowledge and awareness of gynecologic cancers.

Bill Text Versions

View Text
4 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Mar 3, 2021
Introduced in House
Mar 3, 2021
Referred to the House Committee on Energy and Commerce.
Mar 4, 2021
Referred to the Subcommittee on Health.
Jul 15, 2021
Subcommittee Consideration and Mark-up Session Held.
Jul 15, 2021
Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
Jul 21, 2021
Committee Consideration and Mark-up Session Held.
Jul 21, 2021
Ordered to be Reported (Amended) by Voice Vote.
Nov 30, 2021
Placed on the Union Calendar, Calendar No. 132.
Nov 30, 2021
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-182.
Nov 30, 2021
Mr. Pallone moved to suspend the rules and pass the bill, as amended.
Nov 30, 2021
Considered under suspension of the rules. (consideration: CR H6682-6684)
Nov 30, 2021
DEBATE - The House proceeded with forty minutes of debate on H.R. 1550.
Nov 30, 2021
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H6682-6683)
Nov 30, 2021
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H6682-6683)
Nov 30, 2021
Motion to reconsider laid on the table Agreed to without objection.
Dec 1, 2021
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  • March 3, 2021
    Introduced in House


  • March 3, 2021
    Referred to the House Committee on Energy and Commerce.


  • March 4, 2021
    Referred to the Subcommittee on Health.


  • July 15, 2021
    Subcommittee Consideration and Mark-up Session Held.


  • July 15, 2021
    Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .


  • July 21, 2021
    Committee Consideration and Mark-up Session Held.


  • July 21, 2021
    Ordered to be Reported (Amended) by Voice Vote.


  • November 30, 2021
    Placed on the Union Calendar, Calendar No. 132.


  • November 30, 2021
    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-182.


  • November 30, 2021
    Mr. Pallone moved to suspend the rules and pass the bill, as amended.


  • November 30, 2021
    Considered under suspension of the rules. (consideration: CR H6682-6684)


  • November 30, 2021
    DEBATE - The House proceeded with forty minutes of debate on H.R. 1550.


  • November 30, 2021
    Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H6682-6683)


  • November 30, 2021
    On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H6682-6683)


  • November 30, 2021
    Motion to reconsider laid on the table Agreed to without objection.


  • December 1, 2021
    Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Health

Broadcasting, cable, digital technologiesCancerCommunity life and organizationCongressional oversightDigital mediaDrug safety, medical device, and laboratory regulationElementary and secondary educationForeign language and bilingual programsHealth facilities and institutionsHealth programs administration and fundingHealth promotion and preventive careHigher educationImmunology and vaccinationInfectious and parasitic diseasesInternet and video servicesInternet, web applications, social mediaMarketing and advertisingMedical researchMedical tests and diagnostic methodsMinority healthMusculoskeletal and skin diseasesPerformance measurementPublic-private cooperationRural conditions and developmentSex and reproductive healthSexually transmitted diseasesState and local government operationsTelevision and filmWomen's health

PREVENT HPV Cancers Act of 2021

USA117th CongressHR-1550| House 
| Updated: 12/1/2021
Promoting Resources to Expand Vaccination, Education, and New Treatments for HPV Cancers Act of 2021 or the PREVENT HPV Cancers Act of 2021 This bill reauthorizes through FY2026 and expands Department of Health and Human Services activities to educate health care providers and the public about human papillomavirus (HPV), its association with certain cancers, and the importance of HPV vaccines. Specifically, the bill (1) requires relevant educational materials to include information about both cervical cancer and other HPV-associated cancers and about the importance of HPV vaccines, including for males; (2) expands the scope of a national education campaign about gynecologic cancers to address HPV-associated cancers more broadly and target specified, at-risk populations; and (3) authorizes demonstration projects to increase knowledge and awareness of gynecologic cancers.

Bill Text Versions

View Text
4 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Mar 3, 2021
Introduced in House
Mar 3, 2021
Referred to the House Committee on Energy and Commerce.
Mar 4, 2021
Referred to the Subcommittee on Health.
Jul 15, 2021
Subcommittee Consideration and Mark-up Session Held.
Jul 15, 2021
Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
Jul 21, 2021
Committee Consideration and Mark-up Session Held.
Jul 21, 2021
Ordered to be Reported (Amended) by Voice Vote.
Nov 30, 2021
Placed on the Union Calendar, Calendar No. 132.
Nov 30, 2021
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-182.
Nov 30, 2021
Mr. Pallone moved to suspend the rules and pass the bill, as amended.
Nov 30, 2021
Considered under suspension of the rules. (consideration: CR H6682-6684)
Nov 30, 2021
DEBATE - The House proceeded with forty minutes of debate on H.R. 1550.
Nov 30, 2021
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H6682-6683)
Nov 30, 2021
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H6682-6683)
Nov 30, 2021
Motion to reconsider laid on the table Agreed to without objection.
Dec 1, 2021
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  • March 3, 2021
    Introduced in House


  • March 3, 2021
    Referred to the House Committee on Energy and Commerce.


  • March 4, 2021
    Referred to the Subcommittee on Health.


  • July 15, 2021
    Subcommittee Consideration and Mark-up Session Held.


  • July 15, 2021
    Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .


  • July 21, 2021
    Committee Consideration and Mark-up Session Held.


  • July 21, 2021
    Ordered to be Reported (Amended) by Voice Vote.


  • November 30, 2021
    Placed on the Union Calendar, Calendar No. 132.


  • November 30, 2021
    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-182.


  • November 30, 2021
    Mr. Pallone moved to suspend the rules and pass the bill, as amended.


  • November 30, 2021
    Considered under suspension of the rules. (consideration: CR H6682-6684)


  • November 30, 2021
    DEBATE - The House proceeded with forty minutes of debate on H.R. 1550.


  • November 30, 2021
    Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H6682-6683)


  • November 30, 2021
    On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H6682-6683)


  • November 30, 2021
    Motion to reconsider laid on the table Agreed to without objection.


  • December 1, 2021
    Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Kathy Castor

Kathy Castor

Democratic Representative

Florida

Cosponsors (16)
Kim Schrier (Democratic)Stephanie N. Murphy (Democratic)Lisa Blunt Rochester (Democratic)Chrissy Houlahan (Democratic)Darren Soto (Democratic)Raul Ruiz (Democratic)Terri A. Sewell (Democratic)Madeleine Dean (Democratic)Paul Tonko (Democratic)Thomas R. Suozzi (Democratic)Brendan F. Boyle (Democratic)Mark DeSaulnier (Democratic)G. K. Butterfield (Democratic)Marilyn Strickland (Democratic)Mary Gay Scanlon (Democratic)Brian K. Fitzpatrick (Republican)

Health, Education, Labor, and Pensions Committee, Health Subcommittee, Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Broadcasting, cable, digital technologiesCancerCommunity life and organizationCongressional oversightDigital mediaDrug safety, medical device, and laboratory regulationElementary and secondary educationForeign language and bilingual programsHealth facilities and institutionsHealth programs administration and fundingHealth promotion and preventive careHigher educationImmunology and vaccinationInfectious and parasitic diseasesInternet and video servicesInternet, web applications, social mediaMarketing and advertisingMedical researchMedical tests and diagnostic methodsMinority healthMusculoskeletal and skin diseasesPerformance measurementPublic-private cooperationRural conditions and developmentSex and reproductive healthSexually transmitted diseasesState and local government operationsTelevision and filmWomen's health